Who owns ACTINIUM PHARMACEUTICALS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Actinium Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Actinium Pharmaceuticals stock

Who bought or sold ACTINIUM PHARMACEUTICALS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 1.4M $1.9M 3% Dec 2025
 View chart
Acadian Asset Management 606k $823k 24% Dec 2025
 View chart
Millennium Management 602k $818k -4% Dec 2025
 View chart
Renaissance Technologies 391k $532k 35% Dec 2025
 View chart
BlackRock 367k $499k 1% Dec 2025
 View chart
Geode Capital Management 329k $448k 0% Dec 2025
 View chart
Two Sigma Investments 210k $285k -11% Dec 2025
 View chart
Gagnon Securities 202k $275k -11% Dec 2025
 View chart
Two Sigma Advisers 196k $267k 0% Dec 2025
 View chart
State Street Corporation 126k $172k 0% Dec 2025
 View chart
Jane Street 123k $167k 32% Dec 2025
 View chart
Citadel Advisors 115k $156k -24% Dec 2025
 View chart
Gen-Wealth Partners 107k $146k -2% Dec 2025
 View chart
Susquehanna International 96k $130k -22% Dec 2025
 View chart
Goldman Sachs Group 70k $96k 100% Dec 2025
 View chart
Squarepoint Ops 66k $89k 100% Dec 2025
 View chart
Bailard 58k $79k 100% Dec 2025
 View chart
Northern Trust 43k $58k 19% Dec 2025
 View chart
Bridgeway Capital Management 40k $54k 0% Dec 2025
 View chart
Dimensional Fund Advisors 35k $48k 0% Dec 2025
 View chart
Vontobel Holding 30k $41k 0% Dec 2025
 View chart
Am Investment Strategies 29k $40k 100% Dec 2025
 View chart
XTX Topco 26k $35k 30% Dec 2025
 View chart
Callan Family Office 24k $32k 0% Dec 2025
 View chart
Mayport 22k $30k 0% Dec 2025
 View chart
Advisor Group Holdings 20k $28k 183% Dec 2025
 View chart
North Star Asset Management 20k $27k 0% Dec 2025
 View chart
Wells Fargo & Company 20k $27k 0% Dec 2025
 View chart
Qube Research & Technologies 19k $26k -27% Dec 2025
 View chart
Cetera Investment Advisers 15k $21k 5% Dec 2025
 View chart
FMR 14k $20k -32% Dec 2025
 View chart
Russell Investments 13k $18k 0% Dec 2025
 View chart
Hrt Financial 13k $17k 100% Dec 2025
 View chart
Two Sigma Securities 13k $18k 100% Dec 2025
 View chart
Nine Masts Capital 13k $18k 100% Dec 2025
 View chart
Intrepid Financial Planning Group 11k $14k -16% Dec 2025
 View chart
Point72 Asset Management 10k $14k 100% Dec 2025
 View chart
Savvy Advisors 10k $14k 100% Dec 2025
 View chart
Level Four Advisory Services 10k $14k 0% Dec 2025
 View chart
Rockefeller Capital Management 4.0k $5.4k -11% Dec 2025
 View chart
Steward Partners Investment Advisory 2.2k $2.9k 0% Dec 2025
 View chart
Federated Investors 1.4k $1.9k -27% Dec 2025
 View chart
NISA Investment Advisors 958.00 $1.3k 0% Dec 2025
 View chart
National Bank Of Canada /fi/ 855.00 $1.2k 0% Dec 2025
 View chart
SRS Capital Advisors 707.00 $962.014900 1979% Dec 2025
 View chart
CWM 620.00 $999.998000 -56% Dec 2025
 View chart
SBI Securities 542.00 $737.011600 0% Dec 2025
 View chart
Jones Financial Companies, L.L 351.00 $477.009000 0% Dec 2025
 View chart
Pittenger & Anderson 341.00 $463.998700 0% Dec 2025
 View chart
Investors Research Corp 300.00 $299.010000 0% Mar 2026
 View chart
Bnp Paribas Arbitrage, Snc 237.00 $321.988200 0% Dec 2025
 View chart
Northwestern Mutual Wealth Management Company 107.00 $146.001500 0% Dec 2025
 View chart
UBS Group 96.00 $130.905600 -99% Dec 2025
 View chart
EverSource Wealth Advisors 16.00 $22.000000 -81% Dec 2025
 View chart
Barclays 1.00 $1.000000 -75% Dec 2025
 View chart

Who sold out of Actinium Pharmaceuticals?

Fund or Company Name Date Sold Shares Held Valued At
Marshall Wace Sep 2025 26k $42k
AQR Capital Management Sep 2025 17k $27k
Advisory Services Network Sep 2025 2.5k $3.9k
Tower Research Capital Sep 2025 555.00 $888.000000
Group One Trading Sep 2025 547.00 $874.981200
Groupe la Francaise Sep 2025 316.00 $435.985200